Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹235 Cr
up ₹18.9 Cr vs Sep 2019
- Stocks held
- 22
- unchanged
- Top 10 weight
- 64.3%
- of the portfolio in its ten largest
- Cash & debt
- 1.7%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 1
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In October 2019 it disclosed 22 stocks worth ₹235 Cr, up ₹18.9 Cr from Sep 2019. Its largest positions were Sun Pharmaceutical Industries Limited (12.5%), IPCA Laboratories Limited (10.3%), Dr. Reddy's Laboratories Limited (8.5%); the ten largest together made up 64.3% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 68.5% of its equity. Cash and debt stood at 1.7%. Compared with Sep 2019 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
25%
Holds more cash than 25% of peers
What these mean: concentration · cash
Holdings in October 2019
Download CSVEvery line the fund disclosed, with the change against Sep 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 12.53% | up 0.29 pts | ₹29.5 Cr | up ₹3 Cr | Added |
| IPCA Laboratories Limited | 10.35% | up 0.40 pts | ₹24.3 Cr | up ₹2.8 Cr | Added |
| Dr. Reddy's Laboratories Limited | 8.46% | down 0.47 pts | ₹19.9 Cr | up ₹58 L | Added |
| Divi's Laboratories Limited | 6.69% | down 0.21 pts | ₹15.7 Cr | up ₹80 L | Added |
| Apollo Hospitals Enterprise Limited | 5.83% | down 0.13 pts | ₹13.7 Cr | up ₹82 L | Added |
| Indoco Remedies Limited | 4.52% | down 0.03 pts | ₹10.6 Cr | up ₹79 L | Added |
| Jubilant Pharmova Limited | 4.15% | up 0.44 pts | ₹9.8 Cr | up ₹1.7 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 4.11% | down 0.64 pts | ₹9.7 Cr | down ₹60 L | Trimmed |
| Max India Limited | 4.08% | up 0.25 pts | ₹9.6 Cr | up ₹1.3 Cr | Added |
| Abiomed Inc | 3.56% | up 0.78 pts | ₹8.4 Cr | up ₹2.3 Cr | Added |
| Unichem Laboratories Limited | 3.53% | down 0.26 pts | ₹8.3 Cr | up ₹11 L | Added |
| Procter & Gamble Health Limited | 3.42% | down 0.32 pts | ₹8.1 Cr | down ₹4 L | Held |
| Alembic Pharmaceuticals Limited | 3.35% | down 0.02 pts | ₹7.9 Cr | up ₹58 L | Added |
| Abbott India Limited | 3.16% | up 0.07 pts | ₹7.4 Cr | up ₹74 L | Added |
| Syngene International Limited | 3.01% | up 0.29 pts | ₹7.1 Cr | up ₹1.2 Cr | Added |
| Ajanta Pharma Limited | 2.95% | down 0.14 pts | ₹6.9 Cr | up ₹27 L | Added |
| Alkem Laboratories Limited | 2.94% | down 0.11 pts | ₹6.9 Cr | up ₹32 L | Added |
| Abbott Laboratories | 2.81% | down 0.16 pts | ₹6.6 Cr | up ₹18 L | Added |
| Aarti Drugs Limited | 2.72% | up 0.27 pts | ₹6.4 Cr | up ₹1.1 Cr | Added |
| Torrent Pharmaceuticals Limited | 2.46% | down 0.05 pts | ₹5.8 Cr | up ₹35 L | Added |
| Dr. Lal Path Labs Limited | 2.06% | up 0.03 pts | ₹4.8 Cr | up ₹46 L | Added |
| Cash, TREPS & receivables | 1.70% | down 0.31 pts | ₹4 Cr | down ₹36 L | Trimmed |
| ICICI Lombard General Insurance Company Limited | 1.57% | up 0.03 pts | ₹3.7 Cr | up ₹37 L | Added |
What changed, Sep 2019 to Oct 2019
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹3 Cr (+0.29% pts)
- IPCA Laboratories Limitedup ₹2.8 Cr (+0.40% pts)
- Abiomed Incup ₹2.3 Cr (+0.78% pts)
- Jubilant Pharmova Limitedup ₹1.7 Cr (+0.44% pts)
- Max India Limitedup ₹1.3 Cr (+0.25% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2019, the weight rose most in Healthcare Services (+1.2 pts), and fell most in Pharmaceuticals & Biotechnology (−0.7 pts) and Pharmaceuticals (−0.5 pts).
- Healthcare Services17.7% → 18.9%+1.2 pts
- Pharmaceuticals & Biotechnology69.2% → 68.5%−0.7 pts
- Pharmaceuticals11.5% → 11.0%−0.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2019 | Jul 2019 | Sep 2019 | Oct 2019 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.3% | 69.4% | 69.2% | 68.5% |
| Healthcare Services | 14.8% | 16.7% | 17.7% | 18.9% |
| Pharmaceuticals | 12.6% | 11.7% | 11.5% | 11.0% |
| Insurance | 2.3% | 2.2% | 1.6% | 1.6% |
Allocation in Oct 2019change vs Sep 2019
- Pharmaceuticals & Biotechnology (13)68.5%▼ 0.7 pts
- Healthcare Services (5)18.9%▲ 1.2 pts
- Pharmaceuticals (3)11.0%▼ 0.5 pts
- Insurance (1)1.6%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Oct 2019
1.7%
▼ 0.3 pts vs Sep 2019
- Cash alone
- 1.7%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 1.7% – 28.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.